CIENCiena
- Next report
- Dec 10
- Thursday, in 28 days · time not announced yet
- EPS expected
- $1.77
- quarter ending Oct 31, 2026
- Last result
- $1.64Beat
- vs $1.19 expected on Jun 4
- Stock move on it
- −13.66%
- one session
- Price
- $294.04
- −0.68% today · $46.8B cap
Past and upcoming reports
2
| Dec 10, 2026 | Oct 31, 2026 | Time not announced yet | $1.77 | not yet | |
| Jun 4, 2026 | Apr 30, 2026 | Before the market opens | $1.19 | Beat$1.64 | −13.66% |
Pre-earnings read
No pre-earnings read for this report
None for this company right now.
After the report
Jun 4, 2026 report
Ciena beats Q2 EPS estimates by 12.3%, shares rise 2.4% amid strong growth signals
Ciena reported Q2 EPS of $1.64 versus $1.46 estimated, a 12.3% beat, driving a 2.4% stock gain. Despite a high P/E of 148.2, growth metrics remain robust with 47.4% EPS next year growth forecast. Institutional ownership is strong at 96.5%, but recent insider selling and a 15.5% ROE suggest caution. Investors should watch upcoming quarterly revenue and margin execution for growth sustainability.
Reported against expected
Ciena reported Q2 EPS of $1.64, beating estimates of $1.46 by 12.3%.
Guidance
Analyst consensus remains buy-tilted with a $583 target price, implying 30.6% upside from current levels.
How the stock reacted
Shares rose 2.4% on the day of the earnings release, reflecting positive investor response.
What changed
Q2 EPS beat estimates by 12.3%, with EPS at $1.64 versus $1.46 expected.
What the price now assumes
Stock gained 2.4% post-earnings, pricing in continued growth despite high valuation.
What it means for the business
Maintain a growth bias. monitor next-quarter revenue and margin execution for confirmation.
The next one to three months, as we saw it then
Better case30%
Sustained AI-driven demand and margin expansion drive upside beyond analyst targets.
Base case50%
Growth continues at current strong pace with stable margins, supporting current valuation.
Worse case20%
Supply chain issues and insider selling pressure margins and growth, leading to valuation multiple contraction.
If you hold it
Hold unless next-quarter revenue growth falls below 15% or margins drop under 10%.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.